79 /100
CRITICAL RISK
Score updated Jul 06, 2026

NUWE — Nuwellis, Inc. Dilution Risk Tracker

Track NUWE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NUWE — Get alerts when the score changes →

As of July 06, 2026, Nuwellis, Inc. (NUWE) has a DilutionWatch DilutionScore of 79/100, rated CRITICAL dilution risk. Nuwellis, Inc. has a market capitalization of $2.07M, 2.68M shares outstanding. Key dilution vectors include shelf registration capacity of $28.00M, 43.6K outstanding warrants, approximately 2 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
95
📊 Float Risk
15
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
54%
💰 Capital Raise 75%
• Critical: only 1.7 months cash remaining
• Active shelf registration ($28M, 1350% of market cap)
🔄 Reverse Split 45%
• 50-day avg $1.07 approaching $1 threshold
• Only 2 months cash — financial pressure
📉 Score Deterioration 15%
• Score already CRITICAL (79/100) — events likely imminent
🔔 Track NUWE — Get forecast alerts →

💹 Market Data

Market Cap$2.07M
Shares Outstanding2.68M
Float2.61M
Cash$2.08M
Debt$5.90M
Short InterestN/A

🏛 Institutional Holdings

11.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track NUWE for full holder detail →

📉 Short Interest

Short Interest153.9K
Days to Cover1.0
% of Float5.9%
FINRA data as of Jun 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
4 INSIDER TRANSACTION Apr 29, 2026
4 INSIDER TRANSACTION Apr 29, 2026
4 INSIDER TRANSACTION Apr 29, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for NUWE Shareholders

Nuwellis, Inc. (NUWE) carries a DilutionScore of 79/100, placing it in the Critical dilution risk tier — the highest category tracked by DilutionWatch. Companies at this level typically have active capital-raising programs, compressed cash runway, or a combination of dilution vectors that together represent meaningful downside risk to share count. As of July 06, 2026, this score reflects real-time data pulled directly from SEC EDGAR filings.

The most significant dilution vector for NUWE is its shelf registration capacity of $28.0M. A shelf registration (typically an S-3 filing) gives a company pre-approved access to raise capital quickly without a traditional roadshow. The registered amount represents the maximum that can be raised — not necessarily what will be raised — but active shelves combined with tight cash positions are the pattern DilutionWatch monitors most closely. Cash runway is a key watch item: NUWE has approximately 2 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for NUWE in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for NUWE alongside comparable critical-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding Shelf Registrations →
Track NUWE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NUWE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — CRITICAL Risk

Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for NUWE
📊 NUWE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NUWE Signal Convergence & Dark Pool Activity — StonkWhisper 📄 NUWE Dilution Risk Analysis — Full In-Depth Report

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.